Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:33 AM
Ignite Modification Date:
2025-12-25 @ 4:33 AM
NCT ID:
NCT02697318
Eligibility Criteria:
Aim #1:
Inclusion Criteria:
* both male and female participants are being studied
* minimum age of 21 and maximum age of 80
* healthy volunteers with no previous history of eye disease
Exclusion Criteria:
* no medical conditions representing contraindications to use of topical beta-blocker.
* subject must not have any active inflammatory diseases of the eye, or have a diagnosis of any form of glaucoma
Aim #2:
Inclusion Criteria:
* both male and female participants are being studied
* minimum age of 21 and maximum age of 80
* subjects have been diagnosed with primary open angle glaucoma and are stable on monotherapy
Exclusion Criteria:
\- Subjects must have no other ocular disease, or a history of prior ocular trauma, beyond minor corneal abrasion or removal of a superficial corneal foreign body.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
21 Years
Maximum Age:
80 Years
Study:
NCT02697318
Study Brief:
Protocol Section:
NCT02697318